Revising the Role of Myeloid cells in HIV Pathogenesis

Anupriya Aggarwal1, Samantha McAllery, Stuart G Turville

  • 1Laboratory of HIV Biology, Immunovirology and Pathogenesis Program, The Kirby Institute, University of New South Wales, Kensington, NSW, 2010, Australia.

Current HIV/AIDS Reports
|December 18, 2012
PubMed

Insights

Lentiviruses like HIV can infect resting myeloid cells, including macrophages and dendritic cells (DCs). Despite challenges, these cells are crucial

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Lentiviruses, including HIV, infect resting cells like CD4 T cells, macrophages, and dendritic cells (DCs).
  • Myeloid cells (monocytes, macrophages, DCs) are vital for HIV transmission, spread, and serve as viral reservoirs.
  • The discovery of the HIV restriction factor SAMHD1 in myeloid cells prompts re-evaluation of their role in HIV pathogenesis.

Purpose of the Study:

  • To summarize the role of myeloid cells in HIV pathogenesis.
  • To discuss how recent findings reshape the understanding of myeloid cells in HIV infection.
  • To highlight myeloid cells as high-value, low-frequency targets for lentiviral infection.

Main Methods:

  • Literature review and synthesis of current research on myeloid cells and HIV.
  • Analysis of the impact of HIV restriction factors, such as SAMHD1, on myeloid cell permissiveness.
  • Conceptual framework development on myeloid cells as 'quality' rather than 'quantity' HIV substrates.

Main Results:

  • Myeloid cells, despite potential restriction factors, remain significant targets for lentiviral infection.
  • Infection of resting myeloid cells, though infrequent, offers distinct advantages for viral propagation.
  • Recent discoveries have nuanced, but not entirely overturned, the established view of myeloid cells in HIV pathogenesis.

Conclusions:

  • Myeloid cells are critical, albeit challenging, targets for lentiviruses like HIV.
  • The 'quality over quantity' model emphasizes the strategic importance of infecting these specific cell types.
  • Understanding lentiviral interaction with myeloid cells is key to developing effective HIV therapies and interventions.